Aptevo Therapeutics Inc.: multispecific platform to be presented at SITC 2026

What happened Aptevo Therapeutics Inc. announced in a press release dated Oct 14, 2026, that its multispecific platform will be presented at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting. The meeting is scheduled for Nov 4–8, 2026, at the Phoenix Convention Center in Phoenix, Arizona. The press release is attached to the Form 8-K as Exhibit 99.1.

Key details

• Form 8-K was filed Oct 14, 2026 and includes a press release as Exhibit 99.1.
• Presentation scheduled during the SITC 2026 Annual Meeting, Nov 4–8, 2026, Phoenix Convention Center, Phoenix, Arizona.
• The Form 8-K is filed under Item 8.01 (Other events); the filing is signed by Daphne Taylor, Senior Vice President and Chief Financial Officer, dated Oct 14, 2026.

Why it may matter This Form 8-K reports Item 8.01 (Other events), which covers disclosure of events the company chose to report outside other specific item categories. It also includes Item 9.01 (Financial statements and exhibits) to attach the press release as Exhibit 99.1. The filing does not show why the insider traded or why the company acted.